Lion Biotechnologies, Inc.’ CEO Manish Singh, Ph.D., To Chair Opening Session At Phacilitate’s Immunotherapy Forum On January 27
1/24/2014 6:56:39 AM
n Biotechnologies, Inc. (OTCQB: LBIO) announced that Chief Executive Officer Manish Singh, Ph.D., will preside over the introductory session of the Phacilitate Immunotherapy Forum on Monday, January 27, 2014. Titled “Overviewing key trends in immunotherapy R&D investment, collaboration and pipeline strategies,” the session will include presentations by executives from biotechnology and pharmaceutical companies, and a panel discussion with life science industry and venture capital executives.
Help employers find you! Check out all the jobs and post your resume.
comments powered by